Ebglyss FDA approval intensifies competition in atopic dermatitis market: GlobalData
- Posted on October 8, 2024
- By Financial Express
- 2 Views
Ebglyss FDA approval intensifies competition in atopic dermatitis market: GlobalData
Ebglyss' approval highlights the opportunity that exists in the AD space, and may have potential advantages in efficacy and safety against AD, GlobalData stated.
